Abstract
An alkylating tetrapeptide enkephalin derivative, Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone (DAMK) was synthesized, and its binding characteristics on rat brain membranes were evaluated. In competition experiments, the product shows high affinity for the mu opioid binding site of the rat brain membranes, whereas its binding to the delta and kappa subtypes is weak. Micromolar concentrations of this ligand produce a dose-dependent, apparently irreversible inhibition of / 3H/-naloxone binding, with apparent IC 50 value of 1–5 uM. Neither reversibly binding opioids nor tosyl-amino acid chloromethyl ketones show these effects. Saturation binding analysis with / 3H/-naloxone of membranes preincubated with Tyr-D-Ala-Gly-(Me)Phe-CH 2Cl reveal a selective and irreversible inhibition of the high affinity / 3H/-naloxone binding site. Irreversible blockade of mu -selective / 3H/-ligand binding by Tyr-D-Ala-Gly-(Me)Phe-CH 2Cl is much more effective than that of the binding of / 3H/-enkephalin or / 3H/-ethylketocyclazocine. The mu -selective binding properties of this new irreversible enkephalin analogue suggest that it could serve as an affinity label for the mu opioid receptor subtype.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
